RETRACTION : Ivermectin Synergizes Sorafenib in Hepatocellular Carcinoma via Targeting Multiple Oncogenic Pathways

Documenti analoghi

• The Influence of CYP2B6, GSTP1, and SLCO1B1 Star Allele‐Predicted Phenotypes and CBR1 Genetic Variants on Effectiveness Outcomes in Patients With Hepatocellular Carcinoma Receiving Doxorubicin via Transarterial Chemoembolization
  di: Sireen Abdul Rahim Shilbayeh, et al.
  Pubblicazione: (2025)
• Targeting Inflammatory and Oxidative Pathways in Idiopathic Pulmonary Fibrosis: Synergistic Effects of Quercetin and Pirfenidone in Modulating Nrf2/ PPAR ‐γ and TLR ‐4/ NF ‐ κB Pathways
  di: Hanaa Wanas, et al.
  Pubblicazione: (2026)
• Kaempferol Improves Alzheimer's Disease by Inhibiting Neuronal Ferroptosis via Activating GPX4 / AKR1C3 Signaling Pathway
  di: Le Li, et al.
  Pubblicazione: (2026)
• A549 Alveolar Carcinoma Spheroids as a Cytotoxicity Platform for Carboxyl‐ and Amine‐Polyethylene Glycol Gold Nanoparticles
  di: Melissa Petzer, et al.
  Pubblicazione: (2024)
• Mangiferin Against Respiratory Diseases: Pharmacological Targets and Prospects
  di: Kazi Ahsan Ahmed, et al.
  Pubblicazione: (2025)